National surveillance of influenza-associated encephalopathy in Japan over six years, before and during the 2009-2010 influenza pandemic.
Identifieur interne : 000B03 ( PubMed/Corpus ); précédent : 000B02; suivant : 000B04National surveillance of influenza-associated encephalopathy in Japan over six years, before and during the 2009-2010 influenza pandemic.
Auteurs : Yoshiaki Gu ; Tomoe Shimada ; Yoshinori Yasui ; Yuki Tada ; Mitsuo Kaku ; Nobuhiko OkabeSource :
- PloS one [ 1932-6203 ] ; 2013.
English descriptors
- KwdEn :
- Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, Brain Diseases (etiology), Brain Diseases (mortality), Child, Child, Preschool, Disease-Free Survival, Epidemiological Monitoring, Female, Humans, Incidence, Infant, Influenza A Virus, H1N1 Subtype, Influenza, Human (complications), Influenza, Human (mortality), Japan (epidemiology), Male, Middle Aged, Retrospective Studies, Survival Rate.
- MESH :
- geographic , epidemiology : Japan.
- complications : Influenza, Human.
- etiology : Brain Diseases.
- mortality : Brain Diseases, Influenza, Human.
- Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, Child, Child, Preschool, Disease-Free Survival, Epidemiological Monitoring, Female, Humans, Incidence, Infant, Influenza A Virus, H1N1 Subtype, Male, Middle Aged, Retrospective Studies, Survival Rate.
Abstract
Influenza-associated encephalopathy (IAE) is a serious complication of influenza and is reported most frequently in Japan. This paper presents an assessment of the epidemiological characteristics of influenza A (H1N1) 2009-associated encephalopathy in comparison to seasonal IAE, based on Japanese national surveillance data of influenza-like illness (ILI) and IAE during flu seasons from 2004-2005 through 2009-2010. In each season before the pandemic, 34-55 IAE cases (mean 47.8; 95% confidence interval: 36.1-59.4) were reported, and these cases increased drastically to 331 during the 2009 pandemic (6.9-fold the previous seasons). Of the 331 IAE cases, 322 cases were reported as influenza A (H1N1) 2009-associated encephalopathy. The peaks of IAE were consistent with the peaks of the influenza epidemics and pandemics. A total of 570 cases of IAE (seasonal A, 170; seasonal B, 50; influenza A (H1N1) 2009, 322; unknown, 28) were reported over six seasons. The case fatality rate (CFR) ranged from 4.8 to 18.2% before the pandemic seasons and 3.6% in the 2009 pandemic season. The CFR of pandemic-IAE was 3.7%, which is lower than that of influenza A-/B-associated encephalopathy (12.9%, p<0.001; 14.0%, p = 0.002; respectively). The median age of IAE was 7 years during the pandemic, which is higher than that of influenza A-/B-associated encephalopathy (4, p<0.001; 4.5, p = 0.006; respectively). However, the number of pandemic-IAE cases per estimated ILI outpatients peaked in the 0-4-year age group and data both before and during the pandemic season showed a U-shape pattern. This suggests that the high incidence of influenza infection in the 0-4 year age group may lead to a high incidence of IAE in the same age group in a future influenza season. Further studies should include epidemiologic case definitions and clinical details of IAE to gain a more accurate understanding of the epidemiologic status of IAE.
DOI: 10.1371/journal.pone.0054786
PubMed: 23355899
Links to Exploration step
pubmed:23355899Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">National surveillance of influenza-associated encephalopathy in Japan over six years, before and during the 2009-2010 influenza pandemic.</title><author><name sortKey="Gu, Yoshiaki" sort="Gu, Yoshiaki" uniqKey="Gu Y" first="Yoshiaki" last="Gu">Yoshiaki Gu</name><affiliation><nlm:affiliation>Department of Regional Cooperation for Infectious Diseases, Tohoku University Graduate School of Medicine, Sendai, Japan. ygu@med.tohoku.ac.jp</nlm:affiliation></affiliation></author><author><name sortKey="Shimada, Tomoe" sort="Shimada, Tomoe" uniqKey="Shimada T" first="Tomoe" last="Shimada">Tomoe Shimada</name></author><author><name sortKey="Yasui, Yoshinori" sort="Yasui, Yoshinori" uniqKey="Yasui Y" first="Yoshinori" last="Yasui">Yoshinori Yasui</name></author><author><name sortKey="Tada, Yuki" sort="Tada, Yuki" uniqKey="Tada Y" first="Yuki" last="Tada">Yuki Tada</name></author><author><name sortKey="Kaku, Mitsuo" sort="Kaku, Mitsuo" uniqKey="Kaku M" first="Mitsuo" last="Kaku">Mitsuo Kaku</name></author><author><name sortKey="Okabe, Nobuhiko" sort="Okabe, Nobuhiko" uniqKey="Okabe N" first="Nobuhiko" last="Okabe">Nobuhiko Okabe</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:23355899</idno><idno type="pmid">23355899</idno><idno type="doi">10.1371/journal.pone.0054786</idno><idno type="wicri:Area/PubMed/Corpus">000B03</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000B03</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">National surveillance of influenza-associated encephalopathy in Japan over six years, before and during the 2009-2010 influenza pandemic.</title><author><name sortKey="Gu, Yoshiaki" sort="Gu, Yoshiaki" uniqKey="Gu Y" first="Yoshiaki" last="Gu">Yoshiaki Gu</name><affiliation><nlm:affiliation>Department of Regional Cooperation for Infectious Diseases, Tohoku University Graduate School of Medicine, Sendai, Japan. ygu@med.tohoku.ac.jp</nlm:affiliation></affiliation></author><author><name sortKey="Shimada, Tomoe" sort="Shimada, Tomoe" uniqKey="Shimada T" first="Tomoe" last="Shimada">Tomoe Shimada</name></author><author><name sortKey="Yasui, Yoshinori" sort="Yasui, Yoshinori" uniqKey="Yasui Y" first="Yoshinori" last="Yasui">Yoshinori Yasui</name></author><author><name sortKey="Tada, Yuki" sort="Tada, Yuki" uniqKey="Tada Y" first="Yuki" last="Tada">Yuki Tada</name></author><author><name sortKey="Kaku, Mitsuo" sort="Kaku, Mitsuo" uniqKey="Kaku M" first="Mitsuo" last="Kaku">Mitsuo Kaku</name></author><author><name sortKey="Okabe, Nobuhiko" sort="Okabe, Nobuhiko" uniqKey="Okabe N" first="Nobuhiko" last="Okabe">Nobuhiko Okabe</name></author></analytic><series><title level="j">PloS one</title><idno type="eISSN">1932-6203</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Age Factors</term><term>Aged</term><term>Aged, 80 and over</term><term>Brain Diseases (etiology)</term><term>Brain Diseases (mortality)</term><term>Child</term><term>Child, Preschool</term><term>Disease-Free Survival</term><term>Epidemiological Monitoring</term><term>Female</term><term>Humans</term><term>Incidence</term><term>Infant</term><term>Influenza A Virus, H1N1 Subtype</term><term>Influenza, Human (complications)</term><term>Influenza, Human (mortality)</term><term>Japan (epidemiology)</term><term>Male</term><term>Middle Aged</term><term>Retrospective Studies</term><term>Survival Rate</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Japan</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Brain Diseases</term></keywords><keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Brain Diseases</term><term>Influenza, Human</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Age Factors</term><term>Aged</term><term>Aged, 80 and over</term><term>Child</term><term>Child, Preschool</term><term>Disease-Free Survival</term><term>Epidemiological Monitoring</term><term>Female</term><term>Humans</term><term>Incidence</term><term>Infant</term><term>Influenza A Virus, H1N1 Subtype</term><term>Male</term><term>Middle Aged</term><term>Retrospective Studies</term><term>Survival Rate</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Influenza-associated encephalopathy (IAE) is a serious complication of influenza and is reported most frequently in Japan. This paper presents an assessment of the epidemiological characteristics of influenza A (H1N1) 2009-associated encephalopathy in comparison to seasonal IAE, based on Japanese national surveillance data of influenza-like illness (ILI) and IAE during flu seasons from 2004-2005 through 2009-2010. In each season before the pandemic, 34-55 IAE cases (mean 47.8; 95% confidence interval: 36.1-59.4) were reported, and these cases increased drastically to 331 during the 2009 pandemic (6.9-fold the previous seasons). Of the 331 IAE cases, 322 cases were reported as influenza A (H1N1) 2009-associated encephalopathy. The peaks of IAE were consistent with the peaks of the influenza epidemics and pandemics. A total of 570 cases of IAE (seasonal A, 170; seasonal B, 50; influenza A (H1N1) 2009, 322; unknown, 28) were reported over six seasons. The case fatality rate (CFR) ranged from 4.8 to 18.2% before the pandemic seasons and 3.6% in the 2009 pandemic season. The CFR of pandemic-IAE was 3.7%, which is lower than that of influenza A-/B-associated encephalopathy (12.9%, p<0.001; 14.0%, p = 0.002; respectively). The median age of IAE was 7 years during the pandemic, which is higher than that of influenza A-/B-associated encephalopathy (4, p<0.001; 4.5, p = 0.006; respectively). However, the number of pandemic-IAE cases per estimated ILI outpatients peaked in the 0-4-year age group and data both before and during the pandemic season showed a U-shape pattern. This suggests that the high incidence of influenza infection in the 0-4 year age group may lead to a high incidence of IAE in the same age group in a future influenza season. Further studies should include epidemiologic case definitions and clinical details of IAE to gain a more accurate understanding of the epidemiologic status of IAE.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23355899</PMID><DateCompleted><Year>2013</Year><Month>06</Month><Day>24</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2013</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS ONE</ISOAbbreviation></Journal><ArticleTitle>National surveillance of influenza-associated encephalopathy in Japan over six years, before and during the 2009-2010 influenza pandemic.</ArticleTitle><Pagination><MedlinePgn>e54786</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0054786</ELocationID><Abstract><AbstractText>Influenza-associated encephalopathy (IAE) is a serious complication of influenza and is reported most frequently in Japan. This paper presents an assessment of the epidemiological characteristics of influenza A (H1N1) 2009-associated encephalopathy in comparison to seasonal IAE, based on Japanese national surveillance data of influenza-like illness (ILI) and IAE during flu seasons from 2004-2005 through 2009-2010. In each season before the pandemic, 34-55 IAE cases (mean 47.8; 95% confidence interval: 36.1-59.4) were reported, and these cases increased drastically to 331 during the 2009 pandemic (6.9-fold the previous seasons). Of the 331 IAE cases, 322 cases were reported as influenza A (H1N1) 2009-associated encephalopathy. The peaks of IAE were consistent with the peaks of the influenza epidemics and pandemics. A total of 570 cases of IAE (seasonal A, 170; seasonal B, 50; influenza A (H1N1) 2009, 322; unknown, 28) were reported over six seasons. The case fatality rate (CFR) ranged from 4.8 to 18.2% before the pandemic seasons and 3.6% in the 2009 pandemic season. The CFR of pandemic-IAE was 3.7%, which is lower than that of influenza A-/B-associated encephalopathy (12.9%, p<0.001; 14.0%, p = 0.002; respectively). The median age of IAE was 7 years during the pandemic, which is higher than that of influenza A-/B-associated encephalopathy (4, p<0.001; 4.5, p = 0.006; respectively). However, the number of pandemic-IAE cases per estimated ILI outpatients peaked in the 0-4-year age group and data both before and during the pandemic season showed a U-shape pattern. This suggests that the high incidence of influenza infection in the 0-4 year age group may lead to a high incidence of IAE in the same age group in a future influenza season. Further studies should include epidemiologic case definitions and clinical details of IAE to gain a more accurate understanding of the epidemiologic status of IAE.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Yoshiaki</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Regional Cooperation for Infectious Diseases, Tohoku University Graduate School of Medicine, Sendai, Japan. ygu@med.tohoku.ac.jp</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shimada</LastName><ForeName>Tomoe</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Yasui</LastName><ForeName>Yoshinori</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Tada</LastName><ForeName>Yuki</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Kaku</LastName><ForeName>Mitsuo</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Okabe</LastName><ForeName>Nobuhiko</ForeName><Initials>N</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>01</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001927" MajorTopicYN="Y">Brain Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018572" MajorTopicYN="N">Disease-Free Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062665" MajorTopicYN="Y">Epidemiological Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053118" MajorTopicYN="Y">Influenza A Virus, H1N1 Subtype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="Y">Influenza, Human</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>08</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23355899</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0054786</ArticleId><ArticleId IdType="pii">PONE-D-12-23219</ArticleId><ArticleId IdType="pmc">PMC3552950</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pediatr Infect Dis J. 2008 May;27(5):390-5</Citation><ArticleIdList><ArticleId IdType="pubmed">18398387</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2010 Jan;16(1):139-42</Citation><ArticleIdList><ArticleId IdType="pubmed">20031062</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2002 Sep 1;35(5):512-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12173123</ArticleId></ArticleIdList></Reference><Reference><Citation>J Epidemiol. 2003 May;13(3):136-41</Citation><ArticleIdList><ArticleId IdType="pubmed">12749600</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2010 Apr 15;50(8):e50-2</Citation><ArticleIdList><ArticleId IdType="pubmed">20218891</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2009 Dec 10;339:b5213</Citation><ArticleIdList><ArticleId IdType="pubmed">20007665</ArticleId></ArticleIdList></Reference><Reference><Citation>FEBS Lett. 2005 Apr 11;579(10):2040-4</Citation><ArticleIdList><ArticleId IdType="pubmed">15811315</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2003 Mar 1;36(5):567-74</Citation><ArticleIdList><ArticleId IdType="pubmed">12594636</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Radiol. 2010 Feb;40(2):200-5</Citation><ArticleIdList><ArticleId IdType="pubmed">20020117</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(3):e33723</Citation><ArticleIdList><ArticleId IdType="pubmed">22470463</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Virol. 2012 Aug;84(8):1151-6</Citation><ArticleIdList><ArticleId IdType="pubmed">22711342</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Curr. 2009 Dec 20;1:RRN1139</Citation><ArticleIdList><ArticleId IdType="pubmed">20043033</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurocrit Care. 2010 Dec;13(3):396-406</Citation><ArticleIdList><ArticleId IdType="pubmed">20811962</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int. 2005 Jul;68(1):188-92</Citation><ArticleIdList><ArticleId IdType="pubmed">15954908</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2009 Dec 15;49(12):1966-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19929400</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(3):e33536</Citation><ArticleIdList><ArticleId IdType="pubmed">22470453</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2011 Nov;17(11):1993-2000</Citation><ArticleIdList><ArticleId IdType="pubmed">22099086</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2005 Dec 15;353(24):2559-67</Citation><ArticleIdList><ArticleId IdType="pubmed">16354892</ArticleId></ArticleIdList></Reference><Reference><Citation>Microbiol Immunol. 2009 Feb;53(2):83-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19291091</ArticleId></ArticleIdList></Reference><Reference><Citation>Uirusu. 2009 Jun;59(1):59-65</Citation><ArticleIdList><ArticleId IdType="pubmed">19927990</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Neurol. 2009;61(5):289-94</Citation><ArticleIdList><ArticleId IdType="pubmed">19295216</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Infect Dis J. 2005 Jun;24(6):575-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15933579</ArticleId></ArticleIdList></Reference><Reference><Citation>J Paediatr Child Health. 2009 Nov;45(11):660-4</Citation><ArticleIdList><ArticleId IdType="pubmed">19845841</ArticleId></ArticleIdList></Reference><Reference><Citation>CMAJ. 2010 Mar 9;182(4):349-55</Citation><ArticleIdList><ArticleId IdType="pubmed">20159893</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Neurol. 2010 Jun;23(3):305-11</Citation><ArticleIdList><ArticleId IdType="pubmed">20455276</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinsho Shinkeigaku. 2012;52(7):480-5</Citation><ArticleIdList><ArticleId IdType="pubmed">22849989</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Ther. 2012 Oct;29(10):826-48</Citation><ArticleIdList><ArticleId IdType="pubmed">23054689</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Int. 2000 Apr;42(2):187-91</Citation><ArticleIdList><ArticleId IdType="pubmed">10804740</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatrics. 2004 Nov;114(5):e626-33</Citation><ArticleIdList><ArticleId IdType="pubmed">15520093</ArticleId></ArticleIdList></Reference><Reference><Citation>Jpn J Infect Dis. 2002 Feb;55(1):23-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11971158</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B03 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000B03 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= PandemieGrippaleV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:23355899
|texte= National surveillance of influenza-associated encephalopathy in Japan over six years, before and during the 2009-2010 influenza pandemic.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:23355899" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a PandemieGrippaleV1
| This area was generated with Dilib version V0.6.34. |  |